vs
GRAHAM CORP（GHM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
GRAHAM CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$56.7M vs $35.5M），GRAHAM CORP净利率更高（5.0% vs -304.2%，领先309.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 20.5%），GRAHAM CORP自由现金流更多（$2.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 7.5%）
格雷厄姆控股公司是一家多元化的美国控股集团，总部位于弗吉尼亚州阿灵顿县，在特拉华州注册成立，该集团曾是《华盛顿邮报》与《新闻周刊》杂志的所有者。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GHM vs RXRX — 直观对比
营收规模更大
GHM
是对方的1.6倍
$35.5M
营收增速更快
RXRX
高出661.2%
20.5%
净利率更高
GHM
高出309.3%
-304.2%
自由现金流更多
GHM
多$49.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
7.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.7M | $35.5M |
| 净利润 | $2.8M | $-108.1M |
| 毛利率 | 23.8% | 59.8% |
| 营业利润率 | 5.5% | -304.8% |
| 净利率 | 5.0% | -304.2% |
| 营收同比 | 20.5% | 681.7% |
| 净利润同比 | 79.2% | 39.6% |
| 每股收益（稀释后） | $0.25 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GHMRXRX
| Q4 25 | $56.7M | $35.5M | ||
| Q3 25 | $66.0M | $5.2M | ||
| Q2 25 | $55.5M | $19.2M | ||
| Q1 25 | $59.3M | $14.7M | ||
| Q4 24 | $47.0M | $4.5M | ||
| Q3 24 | $53.6M | $26.1M | ||
| Q2 24 | $50.0M | $14.4M | ||
| Q1 24 | $49.1M | $13.8M |
净利润GHMRXRX
| Q4 25 | $2.8M | $-108.1M | ||
| Q3 25 | $3.1M | $-162.3M | ||
| Q2 25 | $4.6M | $-171.9M | ||
| Q1 25 | $4.4M | $-202.5M | ||
| Q4 24 | $1.6M | $-178.9M | ||
| Q3 24 | $3.3M | $-95.8M | ||
| Q2 24 | $3.0M | $-97.5M | ||
| Q1 24 | $1.3M | $-91.4M |
毛利率GHMRXRX
| Q4 25 | 23.8% | 59.8% | ||
| Q3 25 | 21.7% | -183.8% | ||
| Q2 25 | 26.5% | -4.9% | ||
| Q1 25 | 27.0% | -48.0% | ||
| Q4 24 | 24.8% | -181.4% | ||
| Q3 24 | 23.9% | 53.7% | ||
| Q2 24 | 24.8% | 36.2% | ||
| Q1 24 | 25.9% | 19.1% |
营业利润率GHMRXRX
| Q4 25 | 5.5% | -304.8% | ||
| Q3 25 | 6.5% | -3327.6% | ||
| Q2 25 | 8.9% | -916.8% | ||
| Q1 25 | 9.3% | -1297.9% | ||
| Q4 24 | 4.7% | -4042.4% | ||
| Q3 24 | 7.9% | -377.1% | ||
| Q2 24 | 6.5% | -697.4% | ||
| Q1 24 | 3.1% | -698.4% |
净利率GHMRXRX
| Q4 25 | 5.0% | -304.2% | ||
| Q3 25 | 4.7% | -3135.3% | ||
| Q2 25 | 8.3% | -894.2% | ||
| Q1 25 | 7.4% | -1373.3% | ||
| Q4 24 | 3.4% | -3935.5% | ||
| Q3 24 | 6.1% | -367.5% | ||
| Q2 24 | 5.9% | -676.6% | ||
| Q1 24 | 2.7% | -662.4% |
每股收益（稀释后）GHMRXRX
| Q4 25 | $0.25 | $-0.17 | ||
| Q3 25 | $0.28 | $-0.36 | ||
| Q2 25 | $0.42 | $-0.41 | ||
| Q1 25 | $0.40 | $-0.50 | ||
| Q4 24 | $0.14 | $-0.56 | ||
| Q3 24 | $0.30 | $-0.34 | ||
| Q2 24 | $0.27 | $-0.40 | ||
| Q1 24 | $0.11 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.3M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $131.3M | $1.1B |
| 总资产 | $292.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资GHMRXRX
| Q4 25 | $22.3M | $743.3M | ||
| Q3 25 | $20.6M | $659.8M | ||
| Q2 25 | $10.8M | $525.1M | ||
| Q1 25 | $21.6M | $500.5M | ||
| Q4 24 | $30.0M | $594.4M | ||
| Q3 24 | $32.3M | $427.6M | ||
| Q2 24 | $21.6M | $474.3M | ||
| Q1 24 | $16.9M | $296.3M |
总债务GHMRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益GHMRXRX
| Q4 25 | $131.3M | $1.1B | ||
| Q3 25 | $127.6M | $1.0B | ||
| Q2 25 | $123.4M | $919.1M | ||
| Q1 25 | $119.6M | $933.9M | ||
| Q4 24 | $114.4M | $1.0B | ||
| Q3 24 | $112.5M | $524.6M | ||
| Q2 24 | $108.2M | $584.4M | ||
| Q1 24 | $105.6M | $401.2M |
总资产GHMRXRX
| Q4 25 | $292.9M | $1.5B | ||
| Q3 25 | $287.0M | $1.4B | ||
| Q2 25 | $252.3M | $1.3B | ||
| Q1 25 | $264.1M | $1.3B | ||
| Q4 24 | $264.3M | $1.4B | ||
| Q3 24 | $249.5M | $726.5M | ||
| Q2 24 | $244.2M | $775.9M | ||
| Q1 24 | $233.9M | $557.8M |
负债/权益比GHMRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 4.3% | -133.1% |
| 资本支出强度资本支出/营收 | 4.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.67× | — |
| 过去12个月自由现金流最近4个季度 | $-6.1M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流GHMRXRX
| Q4 25 | $4.8M | $-46.1M | ||
| Q3 25 | $13.6M | $-117.4M | ||
| Q2 25 | $-2.3M | $-76.4M | ||
| Q1 25 | $-3.6M | $-132.0M | ||
| Q4 24 | $5.2M | $-115.4M | ||
| Q3 24 | $13.9M | $-59.2M | ||
| Q2 24 | $8.7M | $-82.2M | ||
| Q1 24 | $8.6M | $-102.3M |
自由现金流GHMRXRX
| Q4 25 | $2.4M | $-47.3M | ||
| Q3 25 | $9.4M | $-117.6M | ||
| Q2 25 | $-9.3M | $-79.6M | ||
| Q1 25 | $-8.7M | $-133.8M | ||
| Q4 24 | $-2.1M | $-116.7M | ||
| Q3 24 | $10.4M | $-63.8M | ||
| Q2 24 | $5.7M | $-83.4M | ||
| Q1 24 | $4.6M | $-109.0M |
自由现金流率GHMRXRX
| Q4 25 | 4.3% | -133.1% | ||
| Q3 25 | 14.3% | -2272.5% | ||
| Q2 25 | -16.7% | -413.9% | ||
| Q1 25 | -14.7% | -907.4% | ||
| Q4 24 | -4.5% | -2567.7% | ||
| Q3 24 | 19.5% | -244.6% | ||
| Q2 24 | 11.5% | -578.5% | ||
| Q1 24 | 9.4% | -789.9% |
资本支出强度GHMRXRX
| Q4 25 | 4.1% | 3.5% | ||
| Q3 25 | 6.3% | 4.7% | ||
| Q2 25 | 12.6% | 16.4% | ||
| Q1 25 | 8.7% | 12.4% | ||
| Q4 24 | 15.6% | 28.6% | ||
| Q3 24 | 6.5% | 17.5% | ||
| Q2 24 | 6.0% | 8.2% | ||
| Q1 24 | 8.2% | 48.2% |
现金转化率GHMRXRX
| Q4 25 | 1.67× | — | ||
| Q3 25 | 4.40× | — | ||
| Q2 25 | -0.49× | — | ||
| Q1 25 | -0.81× | — | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 4.25× | — | ||
| Q2 24 | 2.94× | — | ||
| Q1 24 | 6.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
RXRX
暂无分部数据
